Unmet clinical needs in dialysis: What can we do?

Contributions to Nephrology

Volumn 133, Issue , 2001, Pages 1-9

  Ritz, Eberhard ^a,b   Zeier, Martin ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b Division of Nephrology   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; EVALUATION; HUMAN; RENAL REPLACEMENT THERAPY; REVIEW; STANDARD; SURVIVAL;

HUMANS; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; RENAL DIALYSIS; SURVIVAL ANALYSIS;

EID: 0035534292     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000060123     Document Type: Article

References (59)

1. Scribner BH, Buri R, Caner JEZ, Hegstrom R, Burnell JM: The treatment of chronic uremia by means of intermittent hemodialysis: A preliminary report. Trans Am Soc Artif Intern Organs 1960;6:114-122.
2. Scribner BH, Buri R, Caner JE, Hegstrom R, Burnell JM: The treatment of chronic uremia by means of intermittent hemodialysis: A preliminary report. J Am Soc Nephrol 1998;9:719-726.
3. United States Renal Data System: 1999 Annual Report National Institute of Health, National Institute of Diabetes and Digestive of Health, Bethesda, April 1999.
4. Frei U, Schober-Halstenberg HJ and the QUASI Niere Task Force Group for Quality Assurance in Renal Replacement Therapy. NDT 1999;14:1085-1096.
5. Locatelli F, Marcelli D, Conte F, Limido A, Malberti F, Spotti D: Comparison of mortality in ESRD patients on convective and diffusive extracorporeal treatments. The Registro Lombardo Dialisi E Trapianto. Kidney Int 1999;55:286-293.
6. Van Biesen W, Vanholder RC, Veys N, Ditondt A, Lameire NH: An evaluation of an integrative care approach for end-stage renal disease patients. J Am Soc Nephrol 2000;11:116-125.
7. Lameire N: The impact of residual renal function on the adequacy of peritoneal dialysis. Nephron 1997;77:13-28.
8. DOQUI Guidelines National Kidney Foundation Clinical Practice Guidelines, Peritoneal Dialysis, 1997.
9. Dratwa M: Pre-emptive CAPD - What are the arguments? Nephrol Dial Transplant 1999;14:2822-2823.
10. Churchill DN, Thorpe KE, Nolph KD, Keshaviah PR, Oreopoulos DG, Page D: Increased peritoneal membrane transport is associated with decreased patient and technique survival for continuous peritoneal dialysis patients. The Canada-USA (CANUSA) Peritoneal Dialysis Study Group. J Am Soc Nephrol 1998;9:1285-1292.
11. Miranda B, Alvarez IG, Cuende N, Naha MT, de Felipe C: Update on organ donation and retrieval in Spain. Nephrol Dial Transplant 1999;14:842-845.
12. Österreichische Gesellschaft für Nephrologie. Österreichisches Dialyseregister. Nierenersatztherapie in Österreich, Jahresbericht 1998.
13. Gubernatis G, Kliemt H: A superior approach to organ allocation and location. Transplantation 2000;27:699-702.
14. McAlister VC, Gao Z, Peltekian K, Domingues J, Mahalati K, MacDonald AS: Sirolimus-tacrolimus combination immunosuppression. Lancet 2000;355:376-377.
15. Flamand V, Donckier V, Demoor FX, Le Moine A, Matthys P, Vanderhaeghen ML, Tagawa Y, Iwakura Y, Billiau A, Abramowicz D, Goldman M: CD40 ligation prevents neonatal induction of transplantation tolerance. J Immunol 1998;15:4666-4669.
16. Ritz E, Rychlik I, Locatelli F, Halimi S: End-stage renal failure in type 2 diabetes: A medical catastrophe of worldwide dimension. Am J Kidney Dis 1999;34:795-808.
17. Herzog CA, Ma JZ, Collins AJ: Poor long-term survival after acute myocardial infarction among patients with long-term dialysis. N Engl J Med 1998;339:799-805.
18. Van den Hoogen PC, Feskens EJ, Nagelkerke NJ, Menotti A, Nissinen A, Kromhout D: The relation between blood pressure and mortality due to coronary heart disease among men in different parts of the world. Seven Countries Study Research Group. N Engl J Med 2000;342:1-8.
19. Winearls CG, Forman E, Weiffen P, Oliver DO: Recombinant human erythropoietin treatment in patients on maintenance home hemodialysis. Lancet 1998;ii:569.
20. Ritz E, Schömig M, Bommer J: Osteodystrophy in the millennium. Kidney Int 1999;56:S94-S98.
21. Coburn JW, Maung HM: Calcimimetic agents and the calcium-sensing receptor. Curr Opin Nephrol Hypertens 2000;9:123-132.
22. Bonal J, Cleries M, Vela E and the Renal Registry Committee: Transplantation versus haemodialysis in elderly patients. Nephrol Dial Transplant 1997;12:261-264.
23. Wolfe RA, Ashby VB, Milford EL, Ojo AO, Ettenger RE, Agodoa LY, Held PJ, Port FK: Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 1999;341:1725-1730.
24. Charra B, Calemard E, Ruffet M, Chazot C, Terrat JC, Vanel T, Laurent G: Survival as an index of adequacy of dialysis. Kidney Int 1992;42:1286-1291.
25. Zager PG, Nikolic J, Brown RH: 'U'-curve association of blood pressure and mortality in hemodialysis patients. Kidney Int 1998;54:561-569.
26. Sytkowski PA, Kannel WB, D'Agostino RB: Changes in risk factors and the decline in mortality from cardiovascular disease. The Framingham Heart Study. N Engl J Med 1990;322:1635-1641.
27. Zoccali C: Cardiovascular risk in uraemic patients - Is it fully explained by classical risk factors? Nephrol Dial Transplant 2000;15:454-457.
28. Ritz E, Koch M: Morbidity and mortality due to hypertension in patients with renal failure. Am J Kidney Dis 1993;21:113-118.
29. Zuccali A, Zucchelli P: The management of hypotension in dialysed patients. Miner Electrolyte Metab 1999;25:105-108.
30. Krautzig S, Janssen U, Koch KM, Granolleras C, Shaldon S: Dietary salt restriction and reduction of dialysate sodium to control hypertension in maintenance haemodialysis. Nephrol Dial Transplant 1998;13:552-553.
31. Koch M, Thomas B, Tschöpe W, Ritz E: Survival and predictors of death in dialysed diabetic patients. Diabetologia 1993;36:1113-1117.
32. Wanner C, Krane V, Ruf G, März W, Ritz E for die Deutsche Diabetes Dialyse Studie Investigators: Rationale and design of a trial improving outcome of type 2 diabetics on hemodialysis. Kidney Int 1999;56:S222-S226.
33. Degoulet P, Legrain M, Reach I, Aime F, Devries C, Rojas P, Jacobs C: Mortality risk factors in patients treated by chronic hemodialysis. Report of the Diaphane collaborative study. Nephron 1982;31:103-110.
34. Stenvinkel P, Heimbürger O, Lindholm B, Kaysen GA, Bergström J: Are there two types of malnutrition in chronic renal failure? Evidence for relationships between malnutrition, inflammation and atherosclerosis (MIA syndrome). Nephrol Dial Transplant 2000;15:953-960.
35. Kaysen C: Biological basis of hypoalbuminemia in ESRD. Kidney Int 1998;9:2368-2376.
36. Zimmermann J, Herrlinger S, Pruy A, Metzger T, Wanner C: Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 1999;55:648-658.
37. De Sain-Van der Velden MG, de Meer K, Kulik W, Melissant CF, Rabelink TJ, Berger R, Kaysen GA: Nephrotic proteinuria has no net effect on total body protein synthesis: Measurements with (13)C valine. Am J Kidney Dis 2000;35:1149-1154.
38. Witko-Sarsat V, Friedlander M, Nguyen Khoa T, Capeillere-Blandin C, Nguyen AT, Canteloup S, Dayer JM, Jungers P, Drüeke T, Descamps-Latscha B: Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure. J Immunol 1998;161:2524-2532.
39. Krautzig S, Linnenweber S, Schindler R, Shaldon S, Koch KM, Lonnemann W: New indicators to evaluate bacteriological quality of the dialysis fluid and the associated inflammatory response in ESRD patients. Nephrol Dial Transplant 1996;11(suppl 2):S87-S91.
40. Ross R: Atherosclerosis - An inflammatory disease. N Engl J Med 1999;340:115-126.
41. Schömig M, Eisenhardt A, Ritz E: The microinflammatory state of uremia. Blood Purif 2000;18: 327-332.
42. Ridker PM, Hennekens CH, Buring JE, Kundsin R, Shih J: Baseline IgG antibody titers to Chlamydia pneumoniae, Helicobacter pylori, herpes simplex virus, and cytomegalovirus and the risk for cardiovascular disease in women. Ann Intern Med 1999;131:573-577.
43. Block G, Hulberg-Shearon T, Levin N: Association of serum phosphorous and calcium and phosphate product with mortality risk in chronic hemodialysed patients. Am J Kidney Dis 1998;31:607-617.
44. Amann K, Gross ML, London GM, Ritz E: Hyperphosphatemia - A silent killer of patients with renal failure. Nephrol Dial Transplant 1999;14:2085-2087.
45. Braun J, Oldendorf M, Moshage W, Heidleer R, Zeitler E, Luft FC: Electron beam computed tomography in the evaluation of cardiac calcifications in chronic dialysis patients. Am J Kidney Dis 1996;27:394-401.
46. Goodman WG, Goldin J, Kuizon BD, Yoon CH, Gales B, Sider D, Wang Y, Chung J, Emerick A, Greaser L, Elashoff RM, Salusky IB: Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 2000;342:1478-1483.
47. Hergesell O, Ritz E: Phosphate binders on iron basis: A new perspective? Kidney Int 1999;73: S42-S45.
48. Ma JZ, Ebben J, Xia H, Collins AJ: Hematocrit level and associated mortality in hemodialysis patients. J Am Soc Nephrol 1999;10:610-619.
49. Besarab A, Bolton WK, Browne JK, Egrie JC et al.: The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. N Engl J Med 1998;27:584-590.
50. Macdougal I, Ritz E: The normal hematocrit trial in patients with cardiac disease: Are we any the less confused about target hemoglobin? Nephrol Dial Transplant 1998;13:3030-3033.
51. Bonomini V, Mioli V, Albertazzi A, Scolari P: Daily-dialysis programme: Indications and results. Nephrol Dial Transplant 1998;13:2774-2778.
52. Pierratos A, Ouwendyk M, Francoeur R: Nocturnal hemodialysis: Three-year experience. J Am Soc Nephrol 1998;5:859-868.
53. Kooistra MP, Vos J, Koomans MA, Vos P: Daily home hemodialysis in the Netherlands: Effects on metabolic control, hemodynamics and quality of life. Nephrol Dial Transplant 1998;13:2853-2860.
54. Lowrie EG, Lew NL: Death risk in hemodialysis patients: The predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis 1990;15:458-482.
55. Shinzato T, Nakai S, Akiba T, Yamazaki C, Sasaki R, Kitaoka T, Kubo K, Shinoda T, Kurokawa K, Marumo F, Sato T, Maeda K: Current status of renal replacement therapy in Japan: Results of the annual survey of the Japanese Society for Dialysis Therapy. Nephrol Dial Transplant 1996;11: 2143-2150.
56. Koch M, Gradaus F, Schoebel FC, Leschke M, Grabensee B: Relevance of conventional cardiovascular risk factors for the prediction of coronary artery disease in diabetic patients on renal replacement therapy. Nephrol Dial Transplant 1997;12:1187-1191.
57. Foley RN, Parfrey PS, Sarnak MJ: Clinical epidemioloy of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998;32:112S-119S.
58. Keller C, Ritz E, Pommer W, Stein G, Frank J, Schwarzbeck A: The quality of the treatment of diabetics in kidney failure in Germany. Dtsch Med Wschr 2000;125:240-244.
59. Mehrota R, Nolph KD: Argument for timely initiation of dialysis. J Am Soc Nephrol 1998;9:S96-S99.